Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite, a leader in digital investigative solutions, announced the availability of its Endpoint Inspector SaaS on the AWS Marketplace. This solution, part of Cellebrite's Case-to-Closure platform, allows corporate investigators and eDiscovery practitioners to collect and analyze data in real-time from various remote devices. Utilizing AWS cloud infrastructure, Endpoint Inspector SaaS enhances data extraction speed and insight depth for corporate investigations, such as fraud and intellectual property theft. It supports hybrid work environments, enabling secure, consent-based data collection without the need for physical device access. AWS Marketplace facilitates easy deployment, automated billing, and payment tracking.
Leopard Asset Management (LAM) is calling on Sun shareholders to hold the company's management accountable for failing to increase shareholder value. LAM has highlighted Sun's undervaluation, primarily due to its significant holdings in Cellebrite (NASDAQ: CLBT), and other liquid assets.
Since LAM's campaign in March 2024, Sun's share price briefly increased by 23% but fell by 19% after a disappointing AGM agenda was released, indicating a lack of trust in management.
LAM urges shareholders to vote against CEO Ryusuke Utsumi and his team in the upcoming June 25 AGM, citing management's failure to take meaningful action to close the valuation gap.
Sun's shares are valued at ¥7,200 based on liquid assets, far above the current market price of ¥3,300, emphasizing the need for a change in leadership to realize the company's true value.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.